Hao-Teng Chang

Title: Hao-Teng Chang: Innovator in ALS Treatment

Introduction

Hao-Teng Chang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of amyotrophic lateral sclerosis (ALS). His innovative approach has the potential to improve the lives of those affected by this debilitating condition.

Latest Patents

Hao-Teng Chang holds a patent for a method of determining and treating amyotrophic lateral sclerosis. The patent outlines a process that includes measuring the concentration of an autoantibody against high mobility group box 1 protein (HMGB1) in a biological sample. If the concentration exceeds 0.874 µg/ml, an effective amount of ALS-treating drug is administered to the subject. This method represents a significant advancement in the diagnosis and treatment of ALS.

Career Highlights

Throughout his career, Hao-Teng Chang has worked with esteemed institutions such as China Medical University and National Tsing Hua University. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Hao-Teng Chang has collaborated with notable colleagues, including Margaret Dah-Tsyr Chang and Chi-Shin Hwang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hao-Teng Chang's contributions to ALS treatment through his patented method highlight his dedication to advancing medical science. His work not only showcases his innovative spirit but also offers hope for those affected by ALS.